- Home
- ESPR vs SLND Comparison
ESPR vs SLND Comparison
Compare ESPR & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- SLND
- Stock Information
- Founded
- ESPR 2008
- SLND 1900
- Country
- ESPR United States
- SLND United States
- Employees
- ESPR N/A
- SLND N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- ESPR Health Care
- SLND Industrials
- Exchange
- ESPR Nasdaq
- SLND Nasdaq
- Market Cap
- ESPR 208.1M
- SLND 175.8M
- IPO Year
- ESPR 2013
- SLND N/A
- Fundamental
- Price
- ESPR $1.07
- SLND $3.95
- Analyst Decision
- ESPR Buy
- SLND Strong Buy
- Analyst Count
- ESPR 7
- SLND 1
- Target Price
- ESPR $5.93
- SLND $5.00
- AVG Volume (30 Days)
- ESPR 4.1M
- SLND 36.7K
- Earning Date
- ESPR 08-11-2025
- SLND 08-11-2025
- Dividend Yield
- ESPR N/A
- SLND N/A
- EPS Growth
- ESPR N/A
- SLND N/A
- EPS
- ESPR N/A
- SLND N/A
- Revenue
- ESPR $259,574,000.00
- SLND $931,568,000.00
- Revenue This Year
- ESPR $4.07
- SLND $3.76
- Revenue Next Year
- ESPR N/A
- SLND $1.08
- P/E Ratio
- ESPR N/A
- SLND N/A
- Revenue Growth
- ESPR 12.99
- SLND N/A
- 52 Week Low
- ESPR $0.69
- SLND $1.85
- 52 Week High
- ESPR $3.94
- SLND $5.56
- Technical
- Relative Strength Index (RSI)
- ESPR 51.40
- SLND 66.18
- Support Level
- ESPR $1.13
- SLND $3.43
- Resistance Level
- ESPR $1.22
- SLND $4.12
- Average True Range (ATR)
- ESPR 0.08
- SLND 0.19
- MACD
- ESPR 0.00
- SLND -0.00
- Stochastic Oscillator
- ESPR 52.38
- SLND 78.26
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.